140 related articles for article (PubMed ID: 27493618)
21. Differences in breast and cervical cancer screening between West and East Germany: a secondary analysis of a german nationwide health survey.
Großmann LM; Napierala H; Herrmann WJ
BMC Public Health; 2023 Oct; 23(1):1931. PubMed ID: 37798695
[TBL] [Abstract][Full Text] [Related]
22. Breast cancer incidence and mortality before and after implementation of the German mammography screening program.
Katalinic A; Eisemann N; Kraywinkel K; Noftz MR; Hübner J
Int J Cancer; 2020 Aug; 147(3):709-718. PubMed ID: 31675126
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the impact of the mammography screening program on breast cancer mortality: feasibility study on linking several data sources in North Rhine-Westphalia].
Fuhs A; Bartholomäus S; Heidinger O; Hense HW
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):60-7. PubMed ID: 24357174
[TBL] [Abstract][Full Text] [Related]
24. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
25. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
26. Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program.
Hofvind S; Lee CI; Elmore JG
Breast Cancer Res Treat; 2012 Aug; 135(1):291-9. PubMed ID: 22833199
[TBL] [Abstract][Full Text] [Related]
27. Seventeen-years overview of breast cancer inside and outside screening in Denmark.
Domingo L; Jacobsen KK; von Euler-Chelpin M; Vejborg I; Schwartz W; Sala M; Lynge E
Acta Oncol; 2013 Jan; 52(1):48-56. PubMed ID: 22943386
[TBL] [Abstract][Full Text] [Related]
28. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
29. Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography.
Hofvind S; Skaane P; Elmore JG; Sebuødegård S; Hoff SR; Lee CI
Radiology; 2014 Jul; 272(1):52-62. PubMed ID: 24689858
[TBL] [Abstract][Full Text] [Related]
30. Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program.
Hambly NM; McNicholas MM; Phelan N; Hargaden GC; O'Doherty A; Flanagan FL
AJR Am J Roentgenol; 2009 Oct; 193(4):1010-8. PubMed ID: 19770323
[TBL] [Abstract][Full Text] [Related]
31. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
32. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density.
Conant EF; Barlow WE; Herschorn SD; Weaver DL; Beaber EF; Tosteson ANA; Haas JS; Lowry KP; Stout NK; Trentham-Dietz A; diFlorio-Alexander RM; Li CI; Schnall MD; Onega T; Sprague BL;
JAMA Oncol; 2019 May; 5(5):635-642. PubMed ID: 30816931
[TBL] [Abstract][Full Text] [Related]
33. German mammography screening program: adherence, characteristics of (non-)participants and utilization of non-screening mammography-a longitudinal analysis.
Heinig M; Schäfer W; Langner I; Zeeb H; Haug U
BMC Public Health; 2023 Aug; 23(1):1678. PubMed ID: 37653487
[TBL] [Abstract][Full Text] [Related]
34. Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Kuhl CK; Strobel K; Bieling H; Leutner C; Schild HH; Schrading S
Radiology; 2017 May; 283(2):361-370. PubMed ID: 28221097
[TBL] [Abstract][Full Text] [Related]
35. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
[TBL] [Abstract][Full Text] [Related]
36. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
37. Performance indicators evaluation of the population-based breast cancer screening programme in Northern Portugal using the European Guidelines.
Bento MJ; Gonçalves G; Aguiar A; Castro C; Veloso V; Rodrigues V
Cancer Epidemiol; 2015 Oct; 39(5):783-9. PubMed ID: 26315486
[TBL] [Abstract][Full Text] [Related]
38. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
[TBL] [Abstract][Full Text] [Related]
39. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study.
Bluekens AM; Holland R; Karssemeijer N; Broeders MJ; den Heeten GJ
Radiology; 2012 Dec; 265(3):707-14. PubMed ID: 23033499
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
